Sex-based differences in pain outcomes have long been documented clinically, yet the biological mechanisms behind them have remained poorly understood. A newly published study points to immune cell behavior — specifically how monocytes produce an anti-inflammatory molecule — as a likely factor in why women are more prone to developing chronic pain than men.
The research, conducted by a neuroimmunology team, combined animal experiments with data gathered from people who arrived at emergency rooms following motor vehicle collisions. That type of injury was selected deliberately: it is a well-established trigger for long-term musculoskeletal pain, making it a practical model for studying how short-term pain transitions into chronic pain. According to the announcement, the study measured levels of a molecule called interleukin-10 (IL-10) in injured mice and in human patients.
The finding that repositions the field’s assumptions is this: IL-10 does not only suppress inflammation. The research found it communicates directly with pain-sensing nerve cells to deactivate them. In effect, IL-10 helps the body switch pain off. The source of that IL-10, the study found, is predominantly monocytes — immune cells that circulate in the bloodstream and migrate to damaged tissue after injury.
Testosterone as a biological lever
Across both mouse models and human data, male subjects recovered from pain faster than females. The study traces this disparity to monocyte behavior: in males, these immune cells were more likely to produce IL-10 after injury. In females, that response was comparatively weaker.
The study identifies testosterone as a driver of this difference. Higher testosterone levels, the research found, promoted greater IL-10 production by monocytes — suggesting that hormonal signals directly shape the body’s capacity to resolve pain after injury. The finding offers a biological explanation for a pattern that medicine has historically attributed to psychological or social factors, often resulting in undertreated persistent pain in women.
Implications for how pain is treated
The broader significance lies in a conceptual reorientation. Medical understanding has generally positioned the immune system as a source of pain through inflammation. This research argues it is also a mechanism for ending pain — and that differences in how that mechanism functions between sexes may account for divergent recovery trajectories.
The study’s authors suggest that variations in immune cell function could explain not just sex-based differences but why some individuals in general recover from injury while others develop chronic pain conditions. That framing opens potential treatment directions: rather than focusing exclusively on blocking inflammation, therapies might target the resolution side of the immune response — for instance, by modulating monocyte activity or IL-10 production.
For decades, persistent pain in women was frequently dismissed or inadequately addressed in clinical settings. The study’s authors note this directly, situating their findings against a history of pain being attributed to emotional or psychological causes in female patients. A mechanistic, immune-based explanation does not resolve that clinical gap on its own, but it provides a more concrete foundation from which treatment approaches can be developed.
Photo by Fusion Medical Animation on Unsplash
This article is a curated summary based on third-party sources. Source: Read the original article
